Cannabinoid-driven epigenetic remodeling of a chromatin-lipid homeostatic axis via ARID1A uncovers a metabolic vulnerability in cancer
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 25 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 25 samples: 8 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE309010_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1333710 and SRA study SRP626263. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 24 samples.
How we read this: 8 replicated groups read from 25 sample titles; they account for 24 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9258141 HEC-1A UNTREATED Biol rep 1 HEC-1A UNTREATED Biol
- GSM9258142 HEC-1A UNTREATED Biol rep 2 HEC-1A UNTREATED Biol
- GSM9258143 HEC-1A UNTREATED Biol rep 3 HEC-1A UNTREATED Biol
- GSM9258144 HEC-1A THC 20uM 24h Biol rep 1 HEC-1A THC 20uM 24h Biol
- GSM9258145 HEC-1A THC 20uM 24h Biol rep 2 HEC-1A THC 20uM 24h Biol
- GSM9258146 HEC-1A THC 20uM 24h Biol rep 3 HEC-1A THC 20uM 24h Biol
- GSM9258147 HEC-1A THC 20uM 72h Biol rep 1 HEC-1A THC 20uM 72h Biol
- GSM9258148 HEC-1A THC 20uM 72h Biol rep 2 HEC-1A THC 20uM 72h Biol
- GSM9258149 HEC-1A THC 20uM 72h Biol rep 3 HEC-1A THC 20uM 72h Biol
- GSM9258150 HEC-1A, THC 20uM, 24h, ATAC-seq, Biol rep 1 HEC-1A, THC 20uM, 24h, …
- GSM9258151 HEC-1A, THC 20uM, 24h, ATAC-seq, Biol rep 2 HEC-1A, THC 20uM, 24h, …
- GSM9258152 HEC-1A, THC 20uM, 24h, ATAC-seq, Biol rep 3 HEC-1A, THC 20uM, 24h, …
- GSM9258153 HEC-1A, THC 20uM, 72h, ATAC-seq, Biol rep 1 HEC-1A, THC 20uM, 72h, …
- GSM9258154 HEC-1A, THC 20uM, 72h, ATAC-seq, Biol rep 2 HEC-1A, THC 20uM, 72h, …
- GSM9258155 HEC-1A, THC 20uM, 72h, ATAC-seq, Biol rep 3 HEC-1A, THC 20uM, 72h, …
- GSM9258156 HEC-1A, UNTREATED, ATAC-seq, Biol rep 1 HEC-1A, UNTREATED, ATAC…
- GSM9258157 HEC-1A, UNTREATED, ATAC-seq, Biol rep 2 HEC-1A, UNTREATED, ATAC…
- GSM9258158 HEC-1A, UNTREATED, ATAC-seq, Biol rep 3 HEC-1A, UNTREATED, ATAC…
- GSM9258159 HEC-1A, UNTREATED, H3K4me3 (CUT&RUN), Biol rep 1 HEC-1A, UNTREATED, H3K4…
- GSM9258160 HEC-1A, UNTREATED, H3K4me3 (CUT&RUN), Biol rep 2 HEC-1A, UNTREATED, H3K4…
- GSM9258161 HEC-1A, UNTREATED, H3K4me3 (CUT&RUN), Biol rep 3 HEC-1A, UNTREATED, H3K4…
- GSM9258162 HEC-1A, THC 20uM, H3K4me3 (CUT&RUN), Biol rep 1 HEC-1A, THC 20uM, H3K4m…
- GSM9258163 HEC-1A, THC 20uM, H3K4me3 (CUT&RUN), Biol rep 2 HEC-1A, THC 20uM, H3K4m…
- GSM9258164 HEC-1A, THC 20uM, H3K4me3 (CUT&RUN), Biol rep 3 HEC-1A, THC 20uM, H3K4m…
- GSM9258165 HEC-1A, IgG negative control (CUT&RUN)
- GSE319750 ARID1A Deficiency in Diffuse-Type Gastric Cancer Promotes a Pyrimidine Metabolic Vulnerability 14 samples shares arid1a, vulnerability
- GSE234239 Phase Separation of ARID1A Chromatin Remodeling Factor Promotes Oncogenic Potential of Ewing’s Sarcoma 30 samples shares arid1a, remodeling
- GSE263234 ARID1A IDR Targets EWS-FLI1 Condensates and Finetunes Productive Chromatin Remodeling 12 samples shares arid1a, remodeling
- GSE273490 Selective NSD2 Inhibition Reveals an Epigenetic Vulnerability of KRAS-Driven Cancers [CUT&Run] 120 samples shares vulnerability, epigenetic
- GSE273492 Selective NSD2 Inhibition Reveals an Epigenetic Vulnerability of KRAS-Driven Cancers [RNA-Seq] 36 samples shares vulnerability, epigenetic
- GSE324132 Systematic multivariate analysis of chromatin complex dependencies reveals Set1C/COMPASS as a melanoma-enriched epigenetic vulnerability 24 samples shares vulnerability, epigenetic
- GSE256122 Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi/MEKi-resistant melanoma [RNA-seq] 18 samples shares vulnerability, epigenetic
- GSE256123 Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi/MEKi-resistant melanoma [ChIP-seq] 14 samples shares vulnerability, epigenetic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.